Systematic review: the costs of ulcerative colitis in Western countries

Aliment Pharmacol Ther 31, 693–707

[1]  Ashutosh Kumar Singh,et al.  Hidden Cost of Rheumatoid Arthritis (RA): Estimating Cost of Comorbid Cardiovascular Disease and Depression Among Patients with RA , 2009, The Journal of Rheumatology.

[2]  H. Friedman,et al.  Colectomy subtypes, follow‐up surgical procedures, postsurgical complications, and medical charges among ulcerative colitis patients with private health insurance in the United States , 2009, Inflammatory bowel diseases.

[3]  C. Porter,et al.  Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. , 2008, Gastroenterology.

[4]  R. Goetzel,et al.  The Direct and Indirect Cost Burden of Crohn's Disease and Ulcerative Colitis , 2008, Journal of occupational and environmental medicine.

[5]  B. Stuart,et al.  Health Care Expenditures in Ulcerative Colitis: The Perspective of a Self-Insured Employer , 2008, Journal of occupational and environmental medicine.

[6]  S. Bickston,et al.  Administrative Claims Analysis of All-Cause Annual Costs of Care and Resource Utilization by Age Category for Ulcerative Colitis Patients , 2008, Journal of managed care pharmacy : JMCP.

[7]  J. Chao,et al.  The costs of Crohn's disease in the United States and other Western countries: a systematic review , 2008, Current medical research and opinion.

[8]  Ken Kleinman,et al.  The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  S. Brant,et al.  Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004# , 2007, Inflammatory bowel diseases.

[10]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[11]  W. Tindall,et al.  Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs , 2007, Journal of managed care pharmacy : JMCP.

[12]  X. Badia,et al.  Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective? , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  William J. Tremaine,et al.  Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 , 2007, Inflammatory bowel diseases.

[14]  Philippe Marteau,et al.  A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. , 2007, Gastroenterology.

[15]  J. Mackowiak.  A two-stage decision analysis to assess the cost of 5-aminosalicylic acid failure and the economics of balsalazide versus mesalamine in the treatment of ulcerative colitis. , 2006, Managed care interface.

[16]  C. O'Morain,et al.  Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. , 2006, Gastroenterology.

[17]  P. Lakatos,et al.  Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe? , 2006, Postgraduate Medical Journal.

[18]  G. Corrao,et al.  Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  C. Hollenbeak,et al.  Modified Two-Stage Ileal Pouch-Anal Anastomosis: Equivalent Outcomes With Less Resource Utilization , 2005, Diseases of the colon and rectum.

[20]  A. Buchman,et al.  The Education and Employment Status of Patients with Inflammatory Bowel Diseases , 2005, Inflammatory bowel diseases.

[21]  P. Williamson,et al.  Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study , 2004, Gut.

[22]  E. Loftus.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.

[23]  P. Galle,et al.  Current concept of pathophysiological understanding and natural course of ulcerative colitis , 2004, Langenbeck's Archives of Surgery.

[24]  H. König,et al.  Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital , 2004, Journal of gastroenterology and hepatology.

[25]  C. Hollenbeak,et al.  Factors Affecting Cost and Length of Stay Associated With the Ileal Pouch-Anal Anastomosis , 2003, Diseases of the colon and rectum.

[26]  Philip Jacobs,et al.  Work losses related to inflammatory bowel disease in the United States: Results from the National Health Interview Survey , 2003, American Journal of Gastroenterology.

[27]  C. Bernstein,et al.  Work Losses Related to Inflammatory Bowel Disease in Canada: Results From a National Population Health Survey , 2003, American Journal of Gastroenterology.

[28]  W. Whitehead,et al.  Costs of care for irritable bowel syndrome patients in a health maintenance organization , 2001, American Journal of Gastroenterology.

[29]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[30]  C. Bernstein,et al.  Direct hospital costs for patients with inflammatory bowel disease in a Canadian Tertiary Care University Hospital , 2000, American Journal of Gastroenterology.

[31]  R. Cohen,et al.  A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. , 1999, Inflammatory bowel diseases.

[32]  A. Ekbom,et al.  Inflammatory bowel diseases: health care and costs in Sweden in 1994. , 1997, Scandinavian journal of gastroenterology.

[33]  J. Fischer,et al.  Implementation of a clinical pathway decreases length of stay and hospital charges for patients undergoing total colectomy and ileal pouch/anal anastomosis. , 1997, Surgery.

[34]  O. Nielsen,et al.  Changes in extent of ulcerative colitis: a study on the course and prognostic factors. , 1996, Scandinavian journal of gastroenterology.

[35]  A. Ferguson,et al.  Morbidity of juvenile onset inflammatory bowel disease: effects on education and employment in early adult life. , 1994, Gut.

[36]  R. Farmer,et al.  Clinical patterns, natural history, and progression of ulcerative colitis , 1993, Digestive Diseases and Sciences.

[37]  J. Hay,et al.  Inflammatory Bowel Disease: Costs‐of-Illness , 1992, Journal of clinical gastroenterology.

[38]  J. Hay,et al.  Inflammatory Bowel Disease: Medical Cost Algorithms , 1992, Journal of clinical gastroenterology.

[39]  D. Drossman,et al.  Health status and health care use in persons with inflammatory bowel disease , 1991, Digestive Diseases and Sciences.

[40]  C. Leijonmarck,et al.  Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. , 1990, Gut.

[41]  K. Bodger.  Cost of Illness of Crohn’s Disease , 2012, PharmacoEconomics.

[42]  H. König,et al.  Costs of Inflammatory Bowel Disease in Germany , 2012, PharmacoEconomics.

[43]  E. Weiss,et al.  Morbidity of medical therapy for ulcerative colitis: what are we really saving? , 1996, International Journal of Colorectal Disease.

[44]  D. Drossman,et al.  Health status and health care use in persons with inflammatory bowel disease. A national sample. , 1991, Digestive diseases and sciences.

[45]  A. Thomson,et al.  Economic Impact of Inflammatory Bowel Disease in Alberta , 1988 .